Sort
64,565 grants matching “drug discovery”
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant
$2,845,630Kelvin P Lee · Indiana University Indianapolis · P30 · FY2024 · CA
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,844,792David S Stephens · Emory University · UM1 · FY2020 · AI
Neuroimaging and neuromodulation of preclinical models of substance use disorders
$2,844,296Yihong Yang · National Institute On Drug Abuse · ZIA · FY2025 · DA
UCLA Center for Biological Radioprotectors
$2,843,214University Of California Los Angeles · U19 · FY2005 · AI
GInAS - Global Ingredient Archival System
$2,842,774Noel Southall · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
FAMU RCMI Pharmaceutical Research Center
$2,842,409Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2013 · MD
Moffitt Cancer Center Support Grant
$2,842,201Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2014 · CA
Atrial Fibrillation Post-GWAS: Mechanisms to Treatment
$2,841,649Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · P01 · FY2025 · HL
Atrial Fibrillation Post-GWAS: Mechanisms to Treatment
$2,841,649Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · HL
Atrial Fibrillation Post-GWAS: Mechanisms to Treatment
$2,841,649Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · HL
Xavier RCMI Renewal Application-Overall
$2,841,178Guangdi Wang · Xavier University Of Louisiana · U54 · FY2023 · MD
Targeting Cellular Senescence to Extend Healthspan
$2,841,000Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2021 · AG
Moffitt Cancer Center Support Grant
$2,839,647Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2013 · CA
PHARMACEUTICAL RESEARCH CENTER
$2,838,929Florida Agricultural And Mechanical Univ · G12 · FY2004 · RR
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy
$2,837,871Howard N Hodis · University Of Southern California · R01 · FY2021 · AG
Metabolic factors that control the spectrum of human tuberculosis
$2,836,968David Branch Moody · Brigham And Women'S Hospital · U19 · FY2016 · AI
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY
$2,836,953Vanderbilt University · U01 · FY2004 · HL
Targeting Cellular Senescence to Extend Healthspan
$2,835,446Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2022 · AG
Fragment-based discovery of STEP modulators in Alzheimer's disease
$2,835,382Lutz Tautz · Sanford Burnham Prebys Medical Discovery Institute · RF1 · FY2024 · AG
Pharmacogenetics of Membrane Transporters
$2,834,799Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2009 · GM
SAN ANTONIO CANCER INSTITUTE
$2,834,018University Of Texas Hlth Sci Ctr San Ant · P30 · FY2004 · CA
Consolidated Basic Cancer Research Program
$2,833,735Dario C. Altieri · Wistar Institute · P30 · FY2025 · CA
Functional Genomics of Bipolar Disorder
$2,832,352Francis J McMahon · National Institute Of Mental Health · ZIA · FY2021 · MH
Therapies for patients with rare tumors and genetic tumor predisposition
$2,831,748Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
$2,825,827David A Bennett · Rush University Medical Center · R01 · FY2019 · AG